30
Participants
Start Date
April 18, 2018
Primary Completion Date
July 1, 2021
Study Completion Date
August 28, 2021
AMG 596
Drug
AMG 404
Drug
Royal North SHore Hospital, St Leonards
Peter MacCallum Cancer Centre, Melbourne
Memorial Sloan Kettering Cancer Center, New York
Universitatsklinikum Hamburg-Eppendorf, Hamburg
University of California Los Angeles, Los Angeles
Gustave Roussy, Villejuif
Universitaetsklinikum Wuerzburg, Würzburg
Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Dresden
Vrije Universiteit Medisch Centrum, Amsterdam
Hospital Universitari Germans Trias i Pujol, Badalona
Lead Sponsor
Amgen
INDUSTRY